Novo Nordisk A/S-BNONOF
13F holders, Q2 2025 (June 30)3holders +1
1new positions
0sold out
$69.46avg. 13F price*
At the end of Q2 2025, 3 institutions reported holding Novo Nordisk A/S-B (NONOF) in their 13F filings, up 1 from Q1 2025. 1 opened new positions and 0 sold out. The largest holders were Canoe Financial LP ($42.3M), LBMC Investment Advisors, LLC ($504K) and Atlas Capital Advisors Inc. ($362K).
- Company
- Novo Nordisk A/S-B
- CUSIP
- K72807140
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $42.3M |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 609,460 shares bought, net +609,460 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Canoe Financial LP | 0.60% | New | 609,460 | $42.3M |
| LBMC Investment Advisors, LLC | 0.04% | No change | 7,250 | $504K |
| Atlas Capital Advisors Inc. | 0.04% | No change | 5,218 | $362K |
"% of holder's portfolio" is NONOF's weight in each manager's 13F, not the share of Novo Nordisk A/S-B the manager owns.